The Science The IPA/CJC/IGF blend represents the pinnacle of growth hormone optimization, combining three complementary peptides that work through distinct yet synergistic pathways to maximize both GH production and downstream anabolic signaling
Adherence to Therapy: Only 32% of GLP-1 users remained on therapy at the end of year one, dropping to 15% by year two
And while GLP-1 medications have their place, everyday food choices can also support your bodys natural GLP-1 response
Large-scale trials report pancreatitis as uncommon (0.11% of patients) with no clear increased risk versus placebo, though obesity itself is an independent pancreatitis risk factor
Smaller, evenly spaced meals often work better than large, infrequent ones, especially during dose escalation
Those who want to run the exact calculations for their own protocol can use the retatrutide dosage chart for reference